Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Wilson

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
American Journal of Epidemiology|February 3, 2021
A New Method for Estimating the Incidence of Infectious DiseasesHamish McManus, Denton Callander, Jason Asselin, et al.
The Lancet. HIV|November 23, 2025
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countriesRomain Silhol, Ross D Booton, Kate M Mitchell, et al.
Plos One|October 4, 2017
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemicsRobyn M Stuart, Cliff C Kerr, Hassan Haghparast-Bidgoli, et al.
The Lancet. HIV|March 16, 2018
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDSSherrie L Kelly, Rowan Martin-Hughes, Robyn M Stuart, et al.
Plos Computational Biology|September 27, 2021
Optima TB: A tool to help optimally allocate tuberculosis spendingLara Goscé, Gerard J Abou Jaoude, David J Kedziora, et al.
Journal of the International AIDS Society|April 14, 2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countriesRobyn M Stuart, Laura Grobicki, Hassan Haghparast-Bidgoli, et al.
Nature|December 4, 2015
Sustainable HIV treatment in Africa through viral-load-informed differentiated care, Andrew Phillips, Amir Shroufi, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
The Lancet. Gastroenterology & Hepatology|July 31, 2020
Global hepatitis C elimination: an investment frameworkAlisa Pedrana, Jessica Howell, Nick Scott, et al.
American Journal of Epidemiology|February 3, 2021
A New Method for Estimating the Incidence of Infectious DiseasesHamish McManus, Denton Callander, Jason Asselin, et al.
The Lancet. HIV|November 23, 2025
Identifying priority populations for HIV interventions using acquisition and transmission indicators: a combined analysis of 15 mathematical models from ten African countriesRomain Silhol, Ross D Booton, Kate M Mitchell, et al.
Plos One|October 4, 2017
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemicsRobyn M Stuart, Cliff C Kerr, Hassan Haghparast-Bidgoli, et al.
The Lancet. HIV|March 16, 2018
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDSSherrie L Kelly, Rowan Martin-Hughes, Robyn M Stuart, et al.
Plos Computational Biology|September 27, 2021
Optima TB: A tool to help optimally allocate tuberculosis spendingLara Goscé, Gerard J Abou Jaoude, David J Kedziora, et al.
Journal of the International AIDS Society|April 14, 2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countriesRobyn M Stuart, Laura Grobicki, Hassan Haghparast-Bidgoli, et al.
Nature|December 4, 2015
Sustainable HIV treatment in Africa through viral-load-informed differentiated care, Andrew Phillips, Amir Shroufi, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 24